Skip to main content

Dissecting Cellular Heterogeneity, Electronic Notebooks, and Next-Gen Cancer Models: August OCG e-Newsletter

, by OCG Staff

Topics from the Office of Cancer Genomics's August 2019 e-Newsletter.

The latest edition of the Office of Cancer Genomics (OCG) e-Newsletter features single-cell RNA sequencing, applications of next-generation cancer models, the GenePattern Notebook, collecting uniform clinical data, and a perspective piece from OCG staff. OCG is a member office of the Center for Cancer Genomics.

Dissecting Cellular Heterogeneity using Single-cell RNA Sequencing

Anuja Sathe, M.B.B.S., Ph.D. and Hanlee P. Ji, M.D. from Stanford University

Single-cell RNA sequencing enables analysis of the transcriptomes of individual cells, provides information on cell-states, and allows a high-resolution characterization of heterogeneous tumor microenvironments. It can be used to discover therapeutic targets and enable mechanistic understanding of target inhibition, fostering translational applications.

Scientific Applications of Next-Generation Cancer Models

Cindy Kyi, Ph.D.

The Human Cancer Models Initiative (HCMI) is providing the scientific community with next-gen cancer models that more closely resemble primary tumors and are annotated with genomic and clinical data. The article provides examples of how next-gen models have been applied in research.

GenePattern Notebook: Integration of Electronic Notebooks with Bioinformatics Tools for Genomic Data Analysis

Michael Reich from the University of California, San Diego

The GenePattern Notebook is an electronic notebook that enables integrative genomic analyses. These analyses are displayed in a user-friendly form and allows scientists even without programming experience to share, collaborate, and publish the results.

Collecting Uniform Clinical Data for a Community Resource

Eva Tonsing-Carter, Ph.D.

HCMI’s clinical report forms (CRFs) standardize the clinical data collected from participating Tissue Source Sites (TSSs). The article discusses the process of developing cancer type-specific CRFs to ensure uniformity and compatibility for use at TSSs across the globe.

Leveraging a Genomics Background to Facilitate Molecular Characterization of HCMI Models

Lauren Hurd, Ph.D.

In this perspective article, Dr. Lauren Hurd, a new Scientific Program Manager for HCMI, discusses her background in genomics and its applications in her current role.

Find more issues of the OCG e-Newsletter
 

< Older Post

Longitudinal Data from the MMRF Released at the GDC

Newer Post >

All the Childhood Cancer Data in the GDC (So Far)

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Dissecting Cellular Heterogeneity, Electronic Notebooks, and Next-Gen Cancer Models: August OCG e-Newsletter was originally published by the National Cancer Institute.”

Featured Posts

Archive